From the archives of the AFIP - The many faces of osteosarcoma

被引:154
作者
Murphey, MD
Robbin, MR
McRae, GA
Flemming, DJ
Temple, HT
Kransdorf, MJ
机构
[1] UNIFORMED SERV UNIV HLTH SCI,DEPT RADIOL & NUCL MED,BETHESDA,MD 20814
[2] UNIFORMED SERV UNIV HLTH SCI,DEPT SURG,BETHESDA,MD 20814
[3] UNIV MARYLAND,MED CTR,DEPT RADIOL,BALTIMORE,MD 21201
[4] USN,NATL MED CTR,DEPT RADIOL,BETHESDA,MD 20084
[5] ST MARYS HOSP,DEPT RADIOL,RICHMOND,VA
关键词
bone neoplasms; neoplasms; in infants and children; osteosarcoma; CELL OSTEO-SARCOMA; NEOADJUVANT CHEMOTHERAPY; MULTIFOCAL OSTEOSARCOMA; TUMOR; BONE; GRADE; MRI; CT; SCINTIGRAPHY; INVOLVEMENT;
D O I
10.1148/radiographics.17.5.9308111
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Osteosarcoma is the most common primary malignant tumor of bone in adolescents and young adults. It accounts for approximately 15% of all primary bone tumors confirmed at biopsy, There are numerous types of primary osteosarcoma, including intramedullary (high grade, telangiectatic, low grade, small cell, osteosarcomatosis, and gnathic), surface (intracortical, parosteal, periosteal, and high-grade surface), and extraskeletal, Osteosarcoma may also occur as a secondary lesion in association with underlying benign conditions, The identification of osteoid matrix formation and aggressive characteristics usually allows prospective radiologic diagnosis of osteosarcoma, As with all bone tumors, differential diagnosis is best assessed with radiographs, whereas staging is performed with computed tomography or magnetic resonance imaging, Understanding and recognition of the variable appearances of the different varieties of osteosarcoma allow improved patient assessment and are vital for optimal clinical management including diagnosis, biopsy, staging, treatment, and follow-up.
引用
收藏
页码:1205 / 1231
页数:27
相关论文
共 119 条
[1]  
ALLAN CJ, 1971, CANCER, V27, P1121, DOI 10.1002/1097-0142(197105)27:5<1121::AID-CNCR2820270519>3.0.CO
[2]  
2-3
[3]  
AMSTUTZ HC, 1969, CANCER, V24, P923, DOI 10.1002/1097-0142(196911)24:5<923::AID-CNCR2820240509>3.0.CO
[4]  
2-E
[5]  
ANANI AP, 1987, ANN PATHOL, V7, P193
[6]  
AYALA AG, 1989, CANCER-AM CANCER SOC, V64, P2162, DOI 10.1002/1097-0142(19891115)64:10<2162::AID-CNCR2820641031>3.0.CO
[7]  
2-P
[8]  
Bane BL, 1990, CANCER, V66, P2762
[9]  
BERTONI F, 1989, CANCER-AM CANCER SOC, V64, P2591, DOI 10.1002/1097-0142(19891215)64:12<2591::AID-CNCR2820641231>3.0.CO
[10]  
2-4